(Total Views: 100)
Posted On: 01/18/2022 9:52:00 AM
Post# of 36224
$PSYBF PsyBio Therapeutics to Present at the H.C. Wainwright Bioconnect Conference
OXFORD, Ohio and COCONUT CREEK, Fla., Jan. 10, 2022 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"
, an intellectual property driven biotechnology company focusing on discovering and developing new, bespoke, psycho-targeted therapeutics to potentially improve mental and neurological health, today announced that Evan Levine, Chief Executive Officer and Chairman, will present at the H.C. Wainwright Bioconnect Conference.
https://finance.yahoo.com/news/psybio-therape...00415.html
OXFORD, Ohio and COCONUT CREEK, Fla., Jan. 10, 2022 /CNW/ - PsyBio Therapeutics Corp. (TSXV: PSYB) (OTCQB: PSYBF) ("PsyBio" or the "Company"
, an intellectual property driven biotechnology company focusing on discovering and developing new, bespoke, psycho-targeted therapeutics to potentially improve mental and neurological health, today announced that Evan Levine, Chief Executive Officer and Chairman, will present at the H.C. Wainwright Bioconnect Conference. https://finance.yahoo.com/news/psybio-therape...00415.html
(0)
(0)
